News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
David Gandara: The Tale of the Three Bears and EGFR mutation
David Gandara/ilcn.org
Apr 14, 2025, 07:42

David Gandara: The Tale of the Three Bears and EGFR mutation

David Gandara, Co-Director of the Center for Experimental Therapeutics at the UC Davis Comprehensive Cancer Center, shared a post on X:

“Only in Texas!

Lung and Order trial debate. Already, corruption suspected!

David Gandara: The Tale of the Three Bears and EGFR mutation

He also added:

Attorney Joel Neal, a country boy from “down on the Farm” ( Stanford) tells the Tale of the Three Bears and EGFR mutation!

Which bowl is most tasty?

Judge Karen Kelly says: The jury is still out!”

David Gandara: The Tale of the Three Bears and EGFR mutation

 

cancer David Gandara EGFR-mutation fight against cancer Global fight against cancer Joel Neal OncoDaily Oncology UC Davis Comprehensive Cancer Center
Special Coverage
Insight
Aug 1, 2025, 03:35
Estela Rodriguez: For the Incoming Hem-Onc Fellows Network Great Summary of Progress in Lung Cancer
Insight
Aug 1, 2025, 02:30
How Well Osimertinib Works to Control EGFR-Positive Lung Cancer - ECOG-ACRIN Cancer Research Group
Insight
Aug 1, 2025, 02:09
George J. Li: New Systematic Review Outcomes of Definitive Radiotherapy for Comorbid ILD and Early-stage NSCLC
Blog
Jul 31, 2025, 23:25
Jill Feldman: Submit an Abstract for the EGFR Resisters Research Summit
Blog
Jul 31, 2025, 20:01
Are You or a Loved One Navigating a Breast Cancer Diagnosis? - Cancer Services UK
Blog
Jul 31, 2025, 19:44
Addressing Cervical Cancer Inequities in Latin America’s Indigenous Communities - CancerWorld
Blog
Jul 31, 2025, 19:33
Shaban Juma: The Economic Burden of Late Cancer Diagnosis: Why Early Detection Matters
Blog
Jul 31, 2025, 19:20
Donor-Advised Funds Have Become Incredibly Popular
Insight
Jul 31, 2025, 19:08
Pavlos Msaouel: Should We Always Combine Bevacizumab and Erlotinib in Rare Kidney Cancer?
Career
Jul 31, 2025, 18:31
Ramy Sedhom: Grateful for the 2025 ACCC Innovator Award
Insight
Jul 31, 2025, 17:44
Susan G. Komen Announces Major Step Toward Greater Recognition of Inflammatory Breast Cancer
Opinion
Jul 31, 2025, 17:19
Alisher Kahharov: Beyond Treatment - Building a Supportive and Effective Breast Cancer Care System